Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$54.45
0.130.24%
al cierre: -
$54.45
0.000.00%
After hour: Oct 31, 4:04 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Nutrien Ltd ha un obiettivo di prezzo di consenso pari a $66, stabilito in base alle ultime valutazioni degli analisti di 27. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, B of A Securities y JP Morgan il octubre 16, 2025, octubre 14, 2025 y agosto 11, 2025. Con un obiettivo di prezzo medio di $66.67 tra le Wells Fargo, B of A Securities y JP Morgan, c'è un implicito 22.44% upside per Nutrien Ltd da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
B of A Securities
JP Morgan
TD Securities
Scotiabank
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Nutrien
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/16/2025 | 19.38% | Wells Fargo | $61 → $65 | Maintains | Equal-Weight | |||
10/14/2025 | 23.05% | B of A Securities | $67 → $67 | Downgrade | Buy → Neutral | |||
08/11/2025 | 24.89% | JP Morgan | $56 → $68 | Upgrade | Neutral → Overweight | |||
08/11/2025 | 32.23% | TD Securities | $70 → $72 | Maintains | Buy | |||
08/11/2025 | 10.19% | Scotiabank | $62 → $60 | Maintains | Sector Perform | |||
08/07/2025 | 15.7% | UBS | $64 → $63 | Maintains | Neutral | |||
07/23/2025 | 17.54% | UBS | $56 → $64 | Maintains | Neutral | |||
07/17/2025 | 13.87% | Wells Fargo | $59 → $62 | Maintains | Equal-Weight | |||
07/15/2025 | 19.38% | Oppenheimer | $63 → $65 | Maintains | Outperform | |||
07/11/2025 | 21.21% | Jefferies | $63 → $66 | Downgrade | Buy → Hold | |||
07/07/2025 | 17.54% | Barclays | $61 → $64 | Maintains | Equal-Weight | |||
06/26/2025 | 19.38% | Morgan Stanley | $60 → $65 | Maintains | Equal-Weight | |||
06/17/2025 | 24.89% | Raymond James | $68 → $68 | Downgrade | Outperform → Market Perform | |||
05/14/2025 | 12.03% | Barclays | $59 → $61 | Maintains | Equal-Weight | |||
05/14/2025 | 15.7% | B of A Securities | $60 → $63 | Maintains | Buy | |||
05/14/2025 | 13.87% | Scotiabank | $62 → $62 | Downgrade | Sector Outperform → Sector Perform | |||
05/13/2025 | 15.7% | Oppenheimer | $58 → $63 | Maintains | Outperform | |||
05/12/2025 | 8.36% | Wells Fargo | $56 → $59 | Maintains | Equal-Weight | |||
05/12/2025 | 19.38% | RBC Capital | $60 → $65 | Maintains | Outperform | |||
05/09/2025 | 8.36% | Goldman Sachs | $53 → $59 | Maintains | Sell | |||
05/08/2025 | 2.85% | UBS | $52 → $56 | Maintains | Neutral | |||
04/22/2025 | 6.52% | Oppenheimer | $60 → $58 | Maintains | Outperform | |||
04/16/2025 | -4.5% | UBS | $54 → $52 | Maintains | Neutral | |||
03/13/2025 | -2.66% | Goldman Sachs | → $53 | Initiates | → Sell | |||
03/05/2025 | 8.36% | Barclays | $56 → $59 | Maintains | Equal-Weight | |||
02/25/2025 | 21.21% | CIBC | — | $64 → $66 | Maintains | Outperformer | ||
02/24/2025 | 10.19% | RBC Capital | $60 → $60 | Reiterates | Outperform → Outperform | |||
02/24/2025 | 13.87% | Scotiabank | $60 → $62 | Maintains | Sector Outperform | |||
02/21/2025 | 2.85% | Wells Fargo | $53 → $56 | Maintains | Equal-Weight | |||
02/20/2025 | 1.01% | Mizuho | $52 → $55 | Maintains | Neutral | |||
02/20/2025 | -0.83% | UBS | $53 → $54 | Maintains | Neutral | |||
02/10/2025 | 10.19% | Scotiabank | $59 → $60 | Maintains | Sector Outperform | |||
01/28/2025 | -2.66% | UBS | $51 → $53 | Maintains | Neutral | |||
01/28/2025 | -2.66% | Wells Fargo | $52 → $53 | Maintains | Equal-Weight | |||
01/27/2025 | 15.7% | Piper Sandler | $58 → $63 | Maintains | Overweight | |||
01/21/2025 | 2.85% | Barclays | $55 → $56 | Downgrade | Overweight → Equal-Weight | |||
01/13/2025 | 6.52% | Piper Sandler | $50 → $58 | Upgrade | Underweight → Overweight | |||
01/13/2025 | -8.17% | JP Morgan | $40 → $50 | Upgrade | Underweight → Neutral | |||
12/12/2024 | 10.19% | Oppenheimer | → $60 | Initiates | → Outperform | |||
12/10/2024 | 1.01% | CIBC | — | $60 → $55 | Assumes | → Outperformer | ||
12/03/2024 | 10.19% | Raymond James | $58 → $60 | Upgrade | Market Perform → Outperform | |||
10/10/2024 | -6.34% | UBS | $66 → $51 | Downgrade | Buy → Neutral | |||
09/24/2024 | -8.17% | Wells Fargo | $62 → $50 | Downgrade | Overweight → Equal-Weight | |||
09/20/2024 | 10.19% | RBC Capital | $60 → $60 | Reiterates | Outperform → Outperform | |||
09/10/2024 | -2.66% | Goldman Sachs | $69 → $53 | Downgrade | Buy → Neutral | |||
08/16/2024 | 1.01% | Barclays | $68 → $55 | Maintains | Overweight | |||
08/12/2024 | 10.19% | RBC Capital | $60 → $60 | Reiterates | Outperform → Outperform | |||
08/12/2024 | 8.36% | Scotiabank | $66 → $59 | Maintains | Sector Outperform | |||
08/09/2024 | 37.74% | BMO Capital | $80 → $75 | Maintains | Outperform | |||
08/08/2024 | -4.5% | Mizuho | $55 → $52 | Maintains | Neutral | |||
07/16/2024 | 21.21% | Wells Fargo | $68 → $66 | Maintains | Overweight | |||
07/15/2024 | 10.19% | RBC Capital | $70 → $60 | Maintains | Outperform | |||
07/09/2024 | 21.21% | UBS | $67 → $66 | Maintains | Buy | |||
06/11/2024 | 1.01% | Piper Sandler | $56 → $55 | Maintains | Underweight | |||
05/17/2024 | 2.85% | Piper Sandler | $54 → $56 | Maintains | Underweight | |||
05/17/2024 | 2.85% | Mizuho | $54 → $56 | Maintains | Underweight | |||
05/10/2024 | 24.89% | Wells Fargo | $67 → $68 | Maintains | Overweight | |||
05/09/2024 | 8.36% | Mizuho | $54 → $59 | Maintains | Neutral | |||
04/29/2024 | 21.21% | Berenberg | $60 → $66 | Upgrade | Hold → Buy | |||
04/10/2024 | 28.56% | B of A Securities | $73 → $70 | Maintains | Buy | |||
03/26/2024 | 13.87% | Jefferies | → $62 | Initiates | → Buy | |||
03/01/2024 | — | Wolfe Research | — | Initiates | → Outperform | |||
02/29/2024 | -0.83% | Piper Sandler | $68 → $54 | Downgrade | Neutral → Underweight | |||
02/26/2024 | 26.72% | Wells Fargo | $77 → $69 | Maintains | Overweight | |||
02/23/2024 | 28.56% | RBC Capital | $75 → $70 | Maintains | Outperform | |||
02/23/2024 | -11.85% | JP Morgan | $58 → $48 | Downgrade | Neutral → Underweight | |||
02/01/2024 | 43.25% | Goldman Sachs | $88 → $78 | Maintains | Buy | |||
01/19/2024 | 37.74% | Stifel | $72 → $75 | Maintains | Buy | |||
01/12/2024 | 19.38% | Raymond James | $80 → $65 | Downgrade | Outperform → Market Perform | |||
11/14/2023 | 24.89% | Barclays | $64 → $68 | Upgrade | Underweight → Overweight | |||
11/06/2023 | 6.52% | JP Morgan | $70 → $58 | Downgrade | Overweight → Neutral | |||
11/03/2023 | 46.92% | RBC Capital | $85 → $80 | Maintains | Outperform | |||
08/14/2023 | 24.89% | Barclays | $70 → $68 | Downgrade | Overweight → Underweight | |||
08/08/2023 | 56.11% | RBC Capital | → $85 | Reiterates | Outperform → Outperform | |||
08/07/2023 | 34.07% | Piper Sandler | $70 → $73 | Maintains | Neutral | |||
08/04/2023 | 34.07% | Mizuho | $74 → $73 | Maintains | Neutral | |||
07/31/2023 | 52.43% | TD Cowen | $72 → $83 | Upgrade | Hold → Buy | |||
07/26/2023 | 32.23% | HSBC | $81 → $72 | Maintains | Hold | |||
07/25/2023 | 28.56% | Morgan Stanley | $70 → $70 | Reiterates | Equal-Weight → Equal-Weight | |||
07/24/2023 | 50.6% | Wells Fargo | $62 → $82 | Upgrade | Equal-Weight → Overweight | |||
07/19/2023 | 28.56% | Morgan Stanley | $70 → $70 | Reiterates | Equal-Weight → Equal-Weight | |||
07/18/2023 | 122.22% | Goldman Sachs | $136 → $121 | Maintains | Buy | |||
06/08/2023 | 56.11% | B of A Securities | $94 → $85 | Maintains | Buy | |||
06/01/2023 | 28.56% | Barclays | $80 → $70 | Maintains | Overweight | |||
05/30/2023 | 28.56% | Morgan Stanley | $80 → $70 | Maintains | Equal-Weight | |||
05/19/2023 | 43.25% | JP Morgan | $92 → $78 | Maintains | Overweight | |||
05/18/2023 | 28.56% | Piper Sandler | $82 → $70 | Maintains | Neutral | |||
05/17/2023 | -10.01% | Berenberg | $92 → $49 | Downgrade | Buy → Hold | |||
05/16/2023 | 65.29% | BMO Capital | $110 → $90 | Maintains | Outperform | |||
05/15/2023 | 13.87% | Wells Fargo | $82 → $62 | Maintains | Equal-Weight | |||
05/12/2023 | 74.47% | RBC Capital | $100 → $95 | Maintains | Outperform | |||
05/12/2023 | 56.11% | Raymond James | → $85 | Upgrade | Market Perform → Outperform | |||
05/12/2023 | 37.74% | Mizuho | $79 → $75 | Maintains | Neutral | |||
05/12/2023 | 46.92% | Barclays | $93 → $80 | Maintains | Overweight | |||
05/11/2023 | 10.19% | Credit Suisse | $70 → $60 | Reiterates | Underperform → Underperform | |||
04/19/2023 | 94.67% | Goldman Sachs | $119 → $106 | Maintains | Buy | |||
04/14/2023 | 70.8% | Barclays | $95 → $93 | Maintains | Overweight | |||
04/12/2023 | 46.92% | Morgan Stanley | $91 → $80 | Maintains | Equal-Weight | |||
04/10/2023 | 65.29% | Scotiabank | $95 → $90 | Upgrade | Sector Perform → Sector Outperform | |||
04/06/2023 | 81.82% | UBS | $100 → $99 | Maintains | Buy |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Nutrien (NTR)?
El último precio objetivo de Nutrien (NYSE:NTR) fue comunicado por Wells Fargo el octubre 16, 2025. La firma de analistas fijó un precio objetivo para $65.00 que espera NTR a rise dentro de 12 meses (un posible 19.38% upside). 41 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Nutrien (NTR)?
La última calificación de analistas para Nutrien (NYSE:NTR) fue proporcionada por Wells Fargo, y Nutrien mantuvo su equal-weight calificación.
¿Cuándo se produjo la última revisión al alza de Nutrien (NTR)?
La última revisión al alza de Nutrien Ltd se produjo en agosto 11, 2025, cuando JP Morgan elevó su precio objetivo a $68. JP Morgan anteriormente tenía a neutral para Nutrien Ltd.
¿Cuándo fue la última revisión a la baja de Nutrien (NTR)?
La última revisión a la baja de Nutrien Ltd se produjo en octubre 14, 2025, cuando B of A Securities cambió su precio objetivo de $67 a $67 para Nutrien Ltd.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Nutrien (NTR)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Nutrien, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Nutrien se registró el octubre 16, 2025, por lo que la próxima calificación estará disponible en torno al octubre 16, 2026.
¿Es correcta la calificación de los analistas sobre Nutrien (NTR)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Nutrien (NTR) fue un mantuvo con un precio objetivo de $61.00 a $65.00. El precio actual al que cotiza Nutrien (NTR) es de $54.45, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.